Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Griggs

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Clinical Pharmacology and Therapeutics|June 19, 2009
Personalized medicine: a perk of privilege?J J Griggs
Leukemia Research|September 12, 1998
Reducing the toxicity of anticancer therapy: new strategiesJ J Griggs
Anti-Cancer Drugs|January 16, 1999
Recombinant erythropoietin and blood transfusions in cancer chemotherapy-induced anemiaJ J Griggs, N Blumberg
Science (New York, N.Y.)|August 3, 1973
Jewish scientistsJ J Griggs, G P Bodey
Cancer|January 5, 1999
Economic analysis of expensive technologies: the case of erythropoietinJ J Griggs, A I Mushlin
European Journal of Cancer Care|September 14, 2006
Family communication and mental health after breast cancerJ B Mallinger, J J Griggs, C G Shields
American Journal of Hematology|February 1, 1994
Treatment of refractory undifferentiated acute myelogenous leukemia with all-trans-retinoic acidJ J Griggs, S E Henley, J M Rowe
American Journal of Hematology|April 1, 1997
Chronic inflammatory demyelinating polyneuropathy in non-Hodgkin's lymphomaJ J Griggs, C S Commichau, A P Rapoport, et al.
The Journal of Clinical Endocrinology and Metabolism|January 17, 2013
Disease severity and radioactive iodine use for thyroid cancerM R Haymart, D G Muenz, A K Stewart, et al.
American Journal of Hematology|August 6, 1998
Ciprofloxacin plus piperacillin is an equally effective regimen for empiric therapy in febrile neutropenic patients compared with standard therapyJ J Griggs, E A Blair, J R Norton, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Clinical Pharmacology and Therapeutics|June 19, 2009
Personalized medicine: a perk of privilege?J J Griggs
Leukemia Research|September 12, 1998
Reducing the toxicity of anticancer therapy: new strategiesJ J Griggs
Anti-Cancer Drugs|January 16, 1999
Recombinant erythropoietin and blood transfusions in cancer chemotherapy-induced anemiaJ J Griggs, N Blumberg
Science (New York, N.Y.)|August 3, 1973
Jewish scientistsJ J Griggs, G P Bodey
Cancer|January 5, 1999
Economic analysis of expensive technologies: the case of erythropoietinJ J Griggs, A I Mushlin
European Journal of Cancer Care|September 14, 2006
Family communication and mental health after breast cancerJ B Mallinger, J J Griggs, C G Shields
American Journal of Hematology|February 1, 1994
Treatment of refractory undifferentiated acute myelogenous leukemia with all-trans-retinoic acidJ J Griggs, S E Henley, J M Rowe
American Journal of Hematology|April 1, 1997
Chronic inflammatory demyelinating polyneuropathy in non-Hodgkin's lymphomaJ J Griggs, C S Commichau, A P Rapoport, et al.
The Journal of Clinical Endocrinology and Metabolism|January 17, 2013
Disease severity and radioactive iodine use for thyroid cancerM R Haymart, D G Muenz, A K Stewart, et al.
American Journal of Hematology|August 6, 1998
Ciprofloxacin plus piperacillin is an equally effective regimen for empiric therapy in febrile neutropenic patients compared with standard therapyJ J Griggs, E A Blair, J R Norton, et al.
Pageof 1